Timolol eyedrop-induced severe bronchospasm.
A patient with glaucoma simplex and chronic pulmonary obstruction was treated with the non-selective beta-adrenergic blocking agent timolol in ophthalmic solution of 0.25% for 11/2 years, when he had daily asthma attacks. In a provocation test, forced expiratory volume in the first second was reduced by 56% and bradycardia was induced after application of two drops of timolol eyedrops 0.25%. The severe systemic side-effects of timolol, when used as eyedrops, are related to the liver bypass and perhaps to the fast absorption from the cornea. It is suggested that when timolol ophthalmic solution is given for the first time to glaucoma patients with chronic obstructive pulmonary disease, they should be observed for one hour with special reference to difficulty in breathing.
D000368:Aged; D001986:Bronchial Spasm / Q000139:chemically induced*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications; D008297:Male; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000009:adverse effects*; D013999:Timolol / Q000008:administration & dosage / Q000009:adverse effects*
D009883:Ophthalmic Solutions; D011412:Propanolamines; D013999:Timolol